Posted by Michael Wonder on 18 Mar 2021
Drug Utilisation SubCommittee utilisation analysis public release documents
18 March 2021 - The utilisation analysis public release documents from the October 2020 Drug Utilisation SubCommittee meeting are now available.
The Drug Utilisation SubCommittee considered:
- Adrenaline
- Alectinib hydrochloride
- Denosumab
- Eculizumab
- Ibrutinib
- Ocrelizumab
